Oncaspar and Prolixin

• Generic Name: pegaspargase
• Dosage Forms: injection, solution
• Other Brand Names: Oncaspar

Oncaspar is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Oncaspar is used in combination with other cancer medications to treat acute lymphoblastic leukemia. Oncaspar is also used to treat allergic reactions to another cancer medication called asparaginase (Elspar).

Oncaspar may also be used for purposes not listed in this medication guide.

• Generic Name: fluphenazine
• Dosage Forms: Tablets USP and Elixir USP
• Other Brand Names: Permitil, Prolixin, Prolixin Decanoate, Prolixin Enanthate

Prolia (denosumab) is a monoclonal antibody. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage.

The Prolia brand of denosumab is used to treat osteoporosis in postmenopausal women who have high risk of bone fracture.

Prolia is used to increase bone mass in men with osteoporosis with a high risk of bone fracture, and in women and men with a high risk of bone fracture caused by receiving treatments for certain types of cancer.

Prolia is also used to treat glucocorticoid-induced osteoporosis in men and women at high risk of bone fracture.